CEVA earnings up next: Can AI royalties offset revenue dip? By Investing.com

CEVA is expected to report Q1 EPS of $0.02 on revenue of $26.14 million, implying 8% year-over-year revenue growth but a 16% sequential decline from Q4's $31.29 million. Investors are focused on whether AI licensing traction can offset normal seasonal softness, with AI already contributing more than 20% of annual licensing revenue and six customers expected to have silicon by end-2026. The stock trades at $33.72, near its 52-week high of $37.07, while analysts remain at a Strong Buy mean target of $30.33 despite mixed recent target changes.

Analysis

The market is implicitly paying for a conversion event: from lumpy licensing revenue today to recurring royalty streams later. That transition is real, but the timing mismatch matters — CEVA can be “right” on AI adoption and still disappoint for several quarters because design wins only monetize after silicon ramps and customer inventory normalizes. In other words, the near-term P&L is still hostage to seasonality, while the equity is already discounting a durable royalty curve.

The second-order beneficiary is probably not CEVA’s competitors in IP licensing so much as its customers that can get to market with differentiated edge-AI chips faster; if CEVA’s architecture becomes a standard input, the economic value migrates downstream to OEMs and module makers. But the same logic cuts the other way: if customers delay tape-outs or push out volume starts, the “AI optionality” narrative deflates quickly because the visibility window is too short to justify a premium multiple on current earnings power.

Consensus appears to be underestimating how fragile sentiment is around a small-cap licensing model with limited operating leverage until royalties inflect. A modest beat on bookings or design-win commentary could extend the rally, but the setup is asymmetric to any soft guide, because the stock is already trading close to the range high while forward estimates are barely moving. The key tell will be whether management can bridge from announcements to monetization; without that bridge, multiple expansion is likely to stall before fundamentals do.

The cleanest risk is not a catastrophic miss, but a “good but not good enough” print that confirms AI is real while pushing the revenue inflection into late 2025/2026. That would pressure holders who are buying the story rather than the numbers, and could create a 10-15% air pocket even if the quarter itself is directionally fine. Conversely, any evidence of earlier royalty conversion or raised 2026 commentary could re-rate the name quickly because the float is too small for many institutions to wait on proof.

Key Decisions for Investors

• Tactically fade strength into the print: sell/short CEVA into earnings with a 1-2 week horizon if the stock stays near highs, targeting a 10-15% downside on any merely in-line guide; cover immediately if management raises confidence on royalty timing.
• If long the AI licensing theme, prefer MCHP over CEVA for the next 3-6 months: MCHP has more diversified end-market exposure and can absorb delayed CEVA-type royalty timing while still monetizing edge-AI demand.
• For event-driven traders, buy a post-earnings straddle only if implied move is below the market’s likely gap risk; otherwise the better expression is a call spread financed by put spread to capture upside from a rare earlier-than-expected royalty inflection.
• Watch for a pair trade: long MCHP / short CEVA into the next 1-2 quarters if CEVA rallies on narrative alone, because the spread should compress if CEVA cannot convert design wins into revenue while MCHP benefits from actual shipment activity.